{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:45:26Z","timestamp":1792737926403,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.beem.2024.101957","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T22:34:07Z","timestamp":1731623647000},"page":"101957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current views on paediatric phaeochromocytoma and paraganglioma with a focus on newest guidelines"],"prefix":"10.1016","volume":"39","author":[{"given":"Christina","family":"Pamporaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth T.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell [Internet]"},{"issue":"12","key":"10.1016\/j.beem.2024.101957_bib2","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","author":"L\u00f3pez-Jim\u00e9nez","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib3","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of pediatric vs adult pheochromocytomas and paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101957_bib4","article-title":"Genotype\u2013phenotype correlations in paediatric and adolescent phaeochromocytoma and paraganglioma: a cross-sectional study","author":"Seabrook","year":"2023","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.beem.2024.101957_bib5","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa039","article-title":"Pheochromocytoma and paraganglioma in children and adolescents: experience of the french society of pediatric oncology (SFCE)","volume":"4","author":"de Tersant","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.beem.2024.101957_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1353.003","article-title":"Characteristics of pheochromocytoma in a 4- to 20-year-old population","volume":"1073","author":"Barontini","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/ERC-13-0415","article-title":"Long-term prognosis of patients with pediatric pheochromocytoma","volume":"21","author":"Bausch","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib8","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/ERC-12-0339","article-title":"Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients","volume":"20","author":"Casc\u00f3n","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12020-010-9319-3","article-title":"Exercise-induced nausea and vomiting: another sign and symptom of pheochromocytoma and paraganglioma","volume":"37","author":"King","year":"2010","journal-title":"Endocrine"},{"issue":"08","key":"10.1016\/j.beem.2024.101957_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/s-0042-106725","article-title":"Attention deficit hyperactivity disorder in pediatric patients with pheochromocytoma and paraganglioma","volume":"48","author":"Batsis","year":"2016","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12022-016-9452-5","article-title":"Pathology of human pheochromocytoma and paraganglioma xenografts in NSG mice","volume":"28","author":"Powers","year":"2017","journal-title":"Endocr Pathol"},{"issue":"11","key":"10.1016\/j.beem.2024.101957_bib12","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1530\/EC-18-0318","article-title":"Missed clinical clues in patients with pheochromocytoma\/paraganglioma discovered by imaging","volume":"7","author":"Rogowski-Lehmann","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2024.101957_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.901760","article-title":"Biochemical diagnosis of catecholamine-producing tumors of childhood: neuroblastoma, pheochromocytoma and paraganglioma","volume":"13","author":"Eisenhofer","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2024.101957_bib14","unstructured":"Casey R.T. , Hendriks E. , Deal C. et al. , et al. International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents. Nat Rev Endocrinol. 2024 Aug 15;"},{"issue":"8","key":"10.1016\/j.beem.2024.101957_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081121","article-title":"Intricacies of the molecular machinery of catecholamine biosynthesis and secretion by chromaffin cells of the normal adrenal medulla and in pheochromocytoma and paraganglioma","volume":"11","author":"Berends","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1196\/annals.1296.027","article-title":"Leaky catecholamine stores: undue waste or a stress response coping mechanism?","volume":"1018","author":"Eisenhofer","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.beem.2024.101957_bib17","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/jcem.83.6.4870","article-title":"Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors","volume":"83","author":"Eisenhofer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharm Rev"},{"issue":"5","key":"10.1016\/j.beem.2024.101957_bib19","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jcem.87.5.8446","article-title":"Utility of plasma free metanephrines for detecting childhood pheochromocytoma","volume":"87","author":"Weise","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2024.101957_bib20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4158\/EP12050.OR","article-title":"Performance of plasma fractionated free metanephrines by enzyme immunoassay in the diagnosis of pheochromocytoma and paraganglioma in children","volume":"18","author":"Sarathi","year":"2012","journal-title":"Endocr Pr"},{"issue":"11","key":"10.1016\/j.beem.2024.101957_bib21","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated o-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2265.2012.04340.x","article-title":"Rapid circulatory clearances and half-lives of plasma free metanephrines","volume":"77","author":"Eisenhofer","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2024.101957_bib23","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/jcem.83.6.4870","article-title":"Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors","volume":"83","author":"Eisenhofer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib24","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1471-4159.1996.66041565.x","article-title":"Mesenteric organ production, hepatic metabolism, and renal elimination of norepinephrine and its metabolites in humans","volume":"66","author":"Eisenhofer","year":"1996","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib25","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine","volume":"90","author":"Eisenhofer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2024.101957_bib26","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2589-7500(23)00094-8","article-title":"Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort","volume":"5","author":"Pamporaki","year":"2023","journal-title":"Lancet Digit Health"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2125.1981.tb01210.x","article-title":"Renal conversion of plasma DOPA to urine dopamine","volume":"12","author":"Brown","year":"1981","journal-title":"Br J Clin Pharm"},{"issue":"15","key":"10.1016\/j.beem.2024.101957_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.clinbiochem.2016.05.008","article-title":"Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas","volume":"49","author":"Patin","year":"2016","journal-title":"Clin Biochem"},{"issue":"10","key":"10.1016\/j.beem.2024.101957_bib29","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1515\/cclm-2020-0022","article-title":"Blood sampling for metanephrines comparing venipuncture vs. indwelling intravenous cannula in healthy subjects","volume":"58","author":"Eijkelenkamp","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/cen.12327","article-title":"Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions","volume":"80","author":"D\u00e4rr","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2024.101957_bib31","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors","volume":"94","author":"de Jong","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2024.101957_bib32","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1210\/jcem.84.7.5864","article-title":"Sources and physiological significance of plasma dopamine sulfate","volume":"84","author":"Goldstein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib33","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1006\/bbrc.1998.9232","article-title":"Dopamine formation from tyramine by CYP2D6","volume":"249","author":"Hiroi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/clinchem\/39.1.97","article-title":"Determination of metanephrines in plasma by liquid chromatography with electrochemical detection","volume":"39","author":"Lenders","year":"1993","journal-title":"Clin Chem"},{"issue":"Pt 2","key":"10.1016\/j.beem.2024.101957_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1258\/acb.2012.012112","article-title":"Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma","volume":"50","author":"Peitzsch","year":"2013","journal-title":"Ann Clin Biochem"},{"issue":"Pt 1","key":"10.1016\/j.beem.2024.101957_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1258\/acb.2010.010062","article-title":"Establishment of a paediatric age-related reference interval for the measurement of urinary total fractionated metanephrines","volume":"48","author":"Griffin","year":"2011","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/endrev\/bnae001","article-title":"Imaging of pheochromocytomas and paragangliomas","volume":"45","author":"Timmers","year":"2024","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.beem.2024.101957_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2024.101957_bib39","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","article-title":"Von Hippel-Lindau and hereditary pheochromocytoma\/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood","volume":"23","author":"Rednam","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmoldx.2017.04.009","article-title":"PheoSeq","volume":"19","author":"Curr\u00e1s-Freixes","year":"2017","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41379-019-0343-4","article-title":"Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study","volume":"33","author":"Favier","year":"2020","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib42","article-title":"SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice","volume":"9","author":"Casey","year":"2019","journal-title":"Sci Rep [Internet]"},{"issue":"6","key":"10.1016\/j.beem.2024.101957_bib43","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2024.101957_bib44","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/jch.12571","article-title":"Treatment of hypertension in children with catecholamine-secreting tumors: a systematic approach","volume":"17","author":"Romero","year":"2015","journal-title":"J Clin Hypertens"},{"issue":"5","key":"10.1016\/j.beem.2024.101957_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1460-9592.2000.00504.x","article-title":"The perioperative management of children with phaeochromocytoma","volume":"10","author":"Hack","year":"2000","journal-title":"Pediatr Anesth"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinane.2009.01.017","article-title":"Dexmedetomidine and magnesium sulfate in the perioperative management of a child undergoing laparoscopic resection of bilateral pheochromocytomas","volume":"22","author":"Bryskin","year":"2010","journal-title":"J Clin Anesth"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jpedsurg.2011.08.003","article-title":"Minimally invasive adrenalectomy in children","volume":"47","author":"Heloury","year":"2012","journal-title":"J Pedia Surg"},{"issue":"8","key":"10.1016\/j.beem.2024.101957_bib48","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ejendo\/lvae108","article-title":"PRAP study-partial versus radical adrenalectomy in hereditary pheochromocytomas","volume":"191","author":"Xu","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2024.101957_bib50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S2213-8587(23)00038-4","article-title":"Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants","volume":"11","author":"Ta\u00efeb","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41574-023-00926-0","article-title":"Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement","volume":"20","author":"Ta\u00efeb","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib52","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.athoracsur.2017.11.022","article-title":"Resection of intrathoracic paraganglioma with and without cardiopulmonary bypass","volume":"105","author":"Gurrieri","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib53","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ejendo\/lvae113","article-title":"Management and follow-up strategies for patients with head and neck paraganglioma","volume":"191","author":"Richter","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0194599815627667","article-title":"Head and neck paragangliomas: an update on evaluation and management","volume":"154","author":"Moore","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.otc.2014.12.007","article-title":"Contemporary management of jugular paragangliomas","volume":"48","author":"Wanna","year":"2015","journal-title":"Otolaryngol Clin North Am"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020225","article-title":"The value of histological algorithms to predict the malignancy potential of pheochromocytomas and abdominal paragangliomas-a meta-analysis and systematic review of the literature","volume":"11","author":"Stenman","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.beem.2024.101957_bib59","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-021-09675-0","article-title":"Challenges in paragangliomas and pheochromocytomas: from histology to molecular immunohistochemistry","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib61","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00432-020-03138-5","article-title":"Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents","volume":"146","author":"Jochmanova","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib62","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1158\/1078-0432.CCR-18-0139","article-title":"Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma","volume":"25","author":"Job","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00423-021-02129-5","article-title":"Composite phaeochromocytomas-a systematic review of published literature","volume":"407","author":"Dhanasekar","year":"2022","journal-title":"Lange Arch Surg"},{"key":"10.1016\/j.beem.2024.101957_bib64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejca.2022.03.032","article-title":"Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma","volume":"169","author":"Pamporaki","year":"2022","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.beem.2024.101957_bib66","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2967\/jnumed.120.259697","article-title":"Systemic radiopharmaceutical therapy of pheochromocytoma and paraganglioma","volume":"62","author":"Carrasquillo","year":"2021","journal-title":"J Nucl Med"},{"issue":"37","key":"10.1016\/j.beem.2024.101957_bib67","doi-asserted-by":"crossref","first-page":"15879","DOI":"10.1073\/pnas.0907843106","article-title":"Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues","volume":"106","author":"Ziegler","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.beem.2024.101957_bib68","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/02841860701441848","article-title":"Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours","volume":"46","author":"Van Essen","year":"2007","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.beem.2024.101957_bib69","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/cncr.26577","article-title":"Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience","volume":"118","author":"Ayala-Ramirez","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib70","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12672-017-0284-7","article-title":"Controlling tumor progression with cyclophosphamide, vincristine, and dacarbazine treatment improves survival in patients with metastatic and unresectable malignant pheochromocytomas\/paragangliomas","volume":"8","author":"Asai","year":"2017","journal-title":"Horm Cancer"},{"issue":"8","key":"10.1016\/j.beem.2024.101957_bib71","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/cncr.23812","article-title":"Treatment of malignant pheochromocytoma\/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients","volume":"113","author":"Huang","year":"2008","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.beem.2024.101957_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11864-020-00787-z","article-title":"Emerging treatments for advanced\/metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Ilanchezhian","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.beem.2024.101957_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1066208","article-title":"The use of temozolomide in paediatric metastatic phaeochromocytoma\/paraganglioma: a case report and literature review","volume":"13","author":"Urquhart","year":"2022","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2024.101957_bib74","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/ijc.28913","article-title":"SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma","volume":"135","author":"Hadoux","year":"2014","journal-title":"Int J Cancer"},{"issue":"22","key":"10.1016\/j.beem.2024.101957_bib75","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa2110051","article-title":"Belzutifan, a potent HIF2\u03b1 inhibitor, in the Pacak-Zhuang syndrome","volume":"385","author":"Kamihara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2024.101957_bib76","series-title":"European Standards of Care for Children with Cancer","author":"SIOPE","year":"2009"},{"issue":"9","key":"10.1016\/j.beem.2024.101957_bib77","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1470-2045(13)70251-1","article-title":"Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort","volume":"14","author":"Barton","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib78","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jayao.2020.0058","article-title":"Fertility-related concerns and uncertainties in adolescent and young adult childhood cancer survivors","volume":"10","author":"Jardim","year":"2021","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"7","key":"10.1016\/j.beem.2024.101957_bib79","first-page":"15","article-title":"Experiences of female childhood cancer patients and survivors regarding information and counselling on gonadotoxicity risk and fertility preservation at diagnosis: a systematic review","author":"Clasen","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246344","article-title":"Oncofertility care for newly diagnosed girls with cancer in a national pediatric oncology setting, the first full year experience from the Princess M\u00e1xima Center, the PEARL study","volume":"16","author":"van der Perk","year":"2021","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.beem.2024.101957_bib81","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.beem.2024.101957_bib82","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1470-2045(13)70251-1","article-title":"Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort","volume":"14","author":"Barton","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0936-6555(89)80039-1","article-title":"Ovarian failure following abdominal irradiation in childhood: natural history and prognosis","volume":"1","author":"Wallace","year":"1989","journal-title":"Clin Oncol (R Coll Radio)"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib84","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","article-title":"Fertility preservation for young patients with cancer: who is at risk and what can be offered?","volume":"6","author":"Wallace","year":"2005","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib85","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2004.11.038","article-title":"Predicting age of ovarian failure after radiation to a field that includes the ovaries","volume":"62","author":"Wallace","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib86","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejogrb.2003.11.002","article-title":"Testicular function following chemo-radiotherapy","volume":"113","author":"Colpi","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.beem.2024.101957_bib87","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41436-019-0735-3","article-title":"Assessing relatives\u2019 readiness for hereditary cancer cascade genetic testing","volume":"22","author":"Bednar","year":"2020","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.beem.2024.101957_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GIM.0b013e318184137c","article-title":"The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP Working Group","volume":"11","author":"Teutsch","year":"2009","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.beem.2024.101957_bib89","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1210\/clinem\/dgac563","article-title":"Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma","volume":"108","author":"Li","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2024.101957_bib90","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4158\/EP161377.OR","article-title":"Growth rate of paragangliomas related to germline mutations of the SDHx genes","volume":"23","author":"Micha\u0142owska","year":"2017","journal-title":"Endocr Pract"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T16:51:28Z","timestamp":1738342288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1521690X24001337"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101957","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current views on paediatric phaeochromocytoma and paraganglioma with a focus on newest guidelines","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101957"}}